In a dramatic change in fortunes, Novartis has won a major victory in its bid to defend oral multiple sclerosis therapy Gilenya from early generic competition in the US. Things have been looking ...

The NHS has agreed a pair of commercial deals with Merck & Co/MSD and Eisai that will allow hundreds of women with advanced endometrial cancer to get access to life-extending combination therapy.

AUTHORITIES and environmentalists in Zambia fear the long-term impact of an acid spill at a mine that has contaminated a major river and could potentially affect millions of people after signs of ...